Raymond S M Wong Selected Research

eltrombopag

1/2022	Treatment of immune thrombocytopenia with eltrombopag in patients who had and who had not received prior rituximab: post-hoc analysis of the EXTEND study.
1/2020	Comprehensive characterization and resolution of discrepant spectrophotometric bilirubin results in patients on eltrombopag therapy.
1/2018	Eltrombopag for advanced myelodysplastic syndromes or acute myeloid leukaemia and severe thrombocytopenia (ASPIRE): a randomised, placebo-controlled, phase 2 trial.
12/2017	Safety and efficacy of long-term treatment of chronic/persistent ITP with eltrombopag: final results of the EXTEND study.
5/2017	From chronic immune thrombocytopenia to severe aplastic anemia: recent insights into the evolution of eltrombopag.
1/2017	A 2-Year, Longitudinal, Prospective Study of the Effects of Eltrombopag on Bone Marrow in Patients with Chronic Immune Thrombocytopenia.
10/2015	Safety and tolerability of eltrombopag versus placebo for treatment of thrombocytopenia in patients with advanced myelodysplastic syndromes or acute myeloid leukaemia: a multicentre, randomised, placebo-controlled, double-blind, phase 1/2 trial.
1/2015	Thrombophilia in patients with chronic immune thrombocytopenia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Raymond S M Wong Research Topics

Disease

7	Hemorrhage 01/2018 - 01/2003
6	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2022 - 08/2003
6	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020 - 10/2008
5	Thrombocytopenia (Thrombopenia) 01/2018 - 09/2015
4	Anemia 06/2022 - 03/2017
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2018 - 10/2015
3	Neoplasms (Cancer) 04/2016 - 02/2013
2	Chronic Renal Insufficiency 06/2022 - 01/2022
2	Thrombosis (Thrombus) 01/2022 - 01/2018
2	Aplastic Anemia (Anemia, Hypoplastic) 10/2017 - 05/2017
2	Multiple Myeloma 09/2015 - 02/2013
1	Infections 01/2021
1	COVID-19 01/2021
1	Hyperbilirubinemia 01/2020
1	Acute Promyelocytic Leukemia 01/2019
1	Vomiting 01/2018
1	Fatigue 01/2018
1	Fever (Fevers) 01/2018
1	Hypercalcemia (Milk Alkali Syndrome) 01/2018
1	Myocardial Infarction 01/2018
1	Pain (Aches) 01/2018
1	Pneumonia (Pneumonitis) 01/2018
1	Retinal Vein Occlusion 01/2018
1	Acute Kidney Injury (Acute Renal Failure) 01/2018
1	Febrile Neutropenia 01/2018
1	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 10/2017
1	Disease Progression 05/2017
1	Hepatitis C 05/2017
1	Virus Diseases (Viral Diseases) 05/2017
1	Cytopenia 03/2017
1	Interstitial Lung Diseases (Interstitial Lung Disease) 03/2017
1	Hypergammaglobulinemia (Hyperimmunoglobulinemia) 03/2017
1	Castleman Disease (Castleman's Disease) 03/2017
1	Hypoalbuminemia 03/2017
1	Edema (Dropsy) 03/2017
1	Proteinuria 03/2017
1	Cytokine Release Syndrome 03/2017
1	Thrombocytosis (Thrombocythemia) 03/2017
1	Fibrosis (Cirrhosis) 01/2017
1	primary familial and congenital Polycythemia 08/2016
1	Polycythemia (Erythrocytosis) 08/2016
1	Genomic Instability 04/2016
1	Chromosomal Instability (Chromosome Stability) 04/2016
1	Chromosome Aberrations (Chromosome Abnormalities) 04/2016
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 10/2015
1	Hepatocellular Carcinoma (Hepatoma) 10/2015
1	Diarrhea 09/2015
1	Neutropenia 09/2015
1	Thrombophilia 01/2015
1	Hematologic Neoplasms (Hematological Malignancy) 06/2013

Drug/Important Bio-Agent (IBA)

8	eltrombopag FDA Link 01/2022 - 01/2015
3	Inosine Triphosphate (ITP)IBA 12/2017 - 01/2017
3	Proteins (Proteins, Gene)FDA Link 04/2016 - 10/2008
2	Pharmaceutical PreparationsIBA 01/2018 - 09/2015
2	DNA (Deoxyribonucleic Acid)IBA 10/2017 - 10/2015
2	Dexamethasone (Maxidex)FDA LinkGeneric 09/2015 - 08/2003
2	Warfarin (Coumadin)FDA LinkGeneric 01/2012 - 09/2004
1	Thrombopoietin (c-mpl Ligand)IBA 06/2022
1	Erythropoietin FDA Link 06/2022
1	romiplostim FDA Link 01/2022
1	Rituximab (Mabthera)FDA Link 01/2022
1	VaccinesIBA 01/2021
1	HLA-B Antigens (HLA-B)IBA 01/2021
1	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2020
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2020
1	BilirubinIBA 01/2020
1	Clofarabine (Clolar)FDA Link 01/2020
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2019
1	Arsenic Trioxide (Trisenox)FDA Link 01/2019
1	CreatinineIBA 01/2018
1	Thrombopoietin ReceptorsIBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 10/2017
1	Cell-Free Nucleic AcidsIBA 10/2017
1	InterferonsIBA 05/2017
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 05/2017
1	Ribavirin (Virazole)FDA LinkGeneric 05/2017
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 05/2017
1	C-Reactive ProteinIBA 03/2017
1	Interleukin-6 (Interleukin 6)IBA 03/2017
1	CollagenIBA 01/2017
1	Reticulin (Reticular Fiber)IBA 01/2017
1	Oxygen (Dioxygen)IBA 08/2016
1	Hemoglobins (Hemoglobin)IBA 08/2016
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 08/2016
1	hemoglobin TarrantIBA 08/2016
1	Messenger RNA (mRNA)IBA 04/2016
1	Transcription Factors (Transcription Factor)IBA 04/2016
1	ixazomibIBA 09/2015
1	Lenalidomide (CC 5013)FDA Link 09/2015
1	Proteasome InhibitorsIBA 09/2015
1	NucleophosminIBA 06/2013
1	NucleotidesIBA 06/2013
1	MicroRNAs (MicroRNA)IBA 06/2013
1	ChemokinesIBA 02/2013

Therapy/Procedure

7	Therapeutics 06/2022 - 08/2003
1	Hematopoietic Stem Cell Transplantation 01/2020
1	Drug Therapy (Chemotherapy) 01/2019
1	Platelet Transfusion (Blood Platelet Transfusions) 01/2018
1	Liver Transplantation 10/2015
1	Transplantation 10/2015